XML 74 R64.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation Level 4 (Details) (USD $)
9 Months Ended
Sep. 30, 2012
Stock Options [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividend yield 1.80%
Expected volatility 40.80%
Risk-free interest rate 0.80%
Expected holding period 5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of period 13,404,216
Options outstanding at beginning of period, weighted average exercise price $ 7.88
Granted 2,035,400
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 11.17
Exercised 2,852,880
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 6.08
Options outstanding at end of period 12,542,136
Options outstanding at end of period, weighted average exercise price $ 8.82
Options exercisable at March 31, 2012 8,283,698
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 8.31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period (44,600)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 9.61
Restricted Stock [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Nonvested restricted shares at beginning of period 1,165,170
Nonvested restricted shares at beginning of period, weighted average grant date fair value $ 7.53
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 483,170
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 11.18
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 543,761
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 6.21
Nonvested restricted shares at end of period 1,104,579
Nonvested restricted shares at end of period, weighted average grant date fair value $ 9.78